What is the Smart Score?
The Smart Score is a proprietary quantitative stock scoring system based on 8 unique market factors. The score is on a scale of 1-10, with 10 being the best possible score.
Yanuki
ARTICLE DETAIL
SCHD ETF Performance Update (June 2025) | Schwab Dividend ETFs: SCHD vs. SCHY | Schwab Dividend ETFs: A Deep Dive into SCHD and SCHY | Schwab ETF: High-Yielding Dividend Stocks | Schwab US Dividend Equity ETF (SCHD): A Comprehensive Analysis for Long-Term Income | ETF Could Turn $500 Monthly Into a $680,000 Portfolio | SCHD ETF: A Diversified Dividend Investment | Intuit (INTU) Institutional Holdings Update: August 2025 | High-Yielding ETFs for Recurring Income: SCHD and HDV | SCHD ETF Performance Update (June 2025) | Schwab Dividend ETFs: SCHD vs. SCHY | Schwab Dividend ETFs: A Deep Dive into SCHD and SCHY | Schwab ETF: High-Yielding Dividend Stocks | Schwab US Dividend Equity ETF (SCHD): A Comprehensive Analysis for Long-Term Income | ETF Could Turn $500 Monthly Into a $680,000 Portfolio | SCHD ETF: A Diversified Dividend Investment | Intuit (INTU) Institutional Holdings Update: August 2025 | High-Yielding ETFs for Recurring Income: SCHD and HDV
Financial Analysis / ETF Analysis
SCHD ETF Performance Update (June 2025)
This article provides a concise update on the Schwab U.S. Dividend Equity ETF (SCHD) as of June 2025, analyzing its recent performance, analyst ratings, and key holdings.
Key Insights
- SCHD is down 1.68% in the past five days but up 3.82% over the past year.
- TipRanks’ ETF analyst consensus rates SCHD as a Moderate Buy with a $29.71 average price target, implying a 12.57% upside.
- Top holdings with the highest upside potential include Kforce (KFRC), Huntsman (HUN), AMERISAFE, Inc. (AMSF), Halliburton (HAL), and Schlumberger (SLB).
- Holdings with the greatest downside potential are Moelis (MC), Virtus Investment Partners (VRTS), Buckle (BKE), Ford Motor (F), and Skyworks Solutions (SWKS).
- SCHD ETF’s Smart Score is seven, suggesting it will likely perform in line with the market.
In-Depth Analysis
The Schwab U.S. Dividend Equity ETF (SCHD) is a popular choice for investors seeking dividend income and equity exposure. As of June 2025, SCHD has experienced a slight dip in the past five days but has shown positive growth over the past year. TipRanks’ analysis suggests a moderate buy rating, indicating cautious optimism about its future performance.
The ETF’s Smart Score of seven implies market-average performance. Investors should note the holdings with the highest upside and downside potential to understand potential opportunities and risks.
Actionable Takeaway: Review SCHD’s top and bottom holdings to assess alignment with your investment strategy. Consider the analyst consensus and Smart Score for a balanced perspective.
FAQ
What is the analyst consensus for SCHD?
According to TipRanks’ unique ETF analyst consensus, determined based on a weighted average of its holdings’ analyst ratings, SCHD is a Moderate Buy.
Takeaways
- SCHD offers a blend of dividend income and equity exposure.
- Analysts predict a potential upside, but performance is expected to be in line with the market.
- Key holdings with high upside and downside potential can influence investment decisions.
Discussion
Do you think SCHD will outperform the market in the coming year? Let us know!
Share this article with others who need to stay ahead of this trend!
Sources
Disclaimer
This article was compiled by Yanuki using publicly available data and trending information. The content may summarize or reference third-party sources that have not been independently verified. While we aim to provide timely and accurate insights, the information presented may be incomplete or outdated.
All content is provided for general informational purposes only and does not constitute financial, legal, or professional advice. Yanuki makes no representations or warranties regarding the reliability or completeness of the information.
This article may include links to external sources for further context. These links are provided for convenience only and do not imply endorsement.
Always do your own research (DYOR) before making any decisions based on the information presented.